Lin, Kueiyu Joshua http://orcid.org/0000-0003-4564-3715
Schneeweiss, Sebastian
Tesfaye, Helen
D’Andrea, Elvira
Liu, Jun
Lii, Joyce
Murphy, Shawn N.
Gagne, Joshua J.
Article History
First Online: 5 November 2020
Declarations
:
: Dr. Schneeweiss is participating in investigator-initiated grants to the Brigham and Women’s Hospital from Bayer, Vertex, and Boehringer Ingelheim unrelated to the topic of this study. He is a consultant to Aetion Inc., a software manufacturer of which he owns equity. His interests were declared, reviewed, and approved by the Brigham and Women’s Hospital and Mass General Brigham System in accordance with their institutional compliance policies. Dr. Gagne has received salary support from grants from Eli Lilly and Company and Novartis Pharmaceuticals Corporation to the Brigham and Women's Hospital and was a consultant to Optum, Inc., all for unrelated work. Other authors have no conflict of interest to disclose.
: The Mass General Brigham (MGB) institutional review board (IRB) approved the study protocol (#2020P001022).
: Not applicable. The MGB IRB approved the study to be exempt from individual consent as this is a secondary use of routinely collected database.
: Not applicable. The MGB IRB approved the study to be exempt from individual consent as this is a secondary use of routinely collected database.
: The patient-level data that the study was based on are not available due to patient privacy, in compliance of our approved IRB.
: The detailed definitions of our study variables are available in the Supplemental information (Appendix 1).
Free to read: This content has been made available to all.